Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: CCA, CHI, WOM

The Lundquist Institute Announces Next Webinar in Community Science Series


LOS ANGELES, Sept. 22, 2020 /PRNewswire/ -- The Lundquist Institute has announced the second in its new series of online webinars, "The Lundquist Community Science Series." This community service webinar series features internationally-renowned Lundquist investigators and clinician scientists, who will be addressing timely topics on biomedical research and healthcare on a regular basis.

This second webinar event is entitled "COVID-19: Pregnancy, Infants & Children" and will be live online on Wednesday, September 30 at 6pm PDT. Moderated by Lundquist President and CEO Dr. David Meyer, the virtual webinar will include Dr. Lynne M. Smith, Chair of the Department of Pediatrics at Harbor-UCLA, Dr. Ken Zangwill, the Chief of Pediatric Infectious Diseases at Harbor-UCLA, Dr. Soina Dargan, who specializes in neonatal and perinatal care, and Dr. Kristina D. Galyon, a maternal-fetal specialist. They will discuss what is currently known about COVID-19 and its effect on pregnant women, infants and children.

"We are very pleased to present this second webinar in our new series, which will provide information on the latest research, clinical observations and potential implications for pregnant women, infants and children," said Dr. David Meyer, the President and CEO of The Lundquist Institute. "COVID-19 is a dangerous disease and the scientific community has been diligently and rapidly focusing its efforts on identifying potential treatments, as well as safe and efficacious vaccines. This current pandemic, as well as others that may lie ahead, call for continuing and sustained efforts in this regard. Our Lundquist investigators have stepped up to this challenge, and are offering their time and expertise to our community through their participation in this webinar series."

To register for the webinar: https://thelundquistinstitute.zoom.us/webinar/register/WN_U3PQKuL-SyueZtqVrVbhIg. The webinar is scheduled to last for 60-90 minutes to include a Q&A period for those participating in the webinar. For more information: https://lundquist.org/

Contact: Max Benavidez, PhD
[email protected]
310-200-2682

About The Lundquist Institute: Research with Reach

The Lundquist Institute is an engine of innovation with a global reach and a 68-year reputation of improving and saving lives. With its new medical research building, its state-of-the-art incubator, "BioLabs at The Lundquist," existing laboratory and support infrastructure, the Lundquist Institute serves as a hub for the Los Angeles area's burgeoning biotech scene. The research institute has over 100 principal investigators working on more than 600 research studies.

 

SOURCE The Lundquist Institute


These press releases may also interest you

at 18:00
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 18:00
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

at 17:52
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

at 16:30
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: